2
TERT (134) 1p/19q (8) IDH1(20) All glioblastomas (200) Supplementary Fig. 1 None=51 Primary glioblastomas (179) 3 3 2 4 13 124 TERT (4) IDH1(14) 124 3 2 Secondary glioblastomas (21) 1p/19q (3) 1p/19q (5) TERT (127) None=50 IDH1(21)

TERT (134)

Embed Size (px)

DESCRIPTION

Supplementary Fig. 1. All glioblastomas (200). Primary glioblastomas (179). Secondary glioblastomas (21). TERT (134). IDH1 (14). TERT (127). TERT (4). 124. 124. IDH1 (21). 3. 4. 3. None=51. 3 2. 13. None=50. 2. 1p/19q (3). 1p/19q (5). 1p/19q (8). IDH1 (20). - PowerPoint PPT Presentation

Citation preview

TERT (134)

1p/19q (8) IDH1(20)

All glioblastomas(200)

Supplementary Fig. 1

None=51

Primary glioblastomas (179)

33

2

4

13

124

TERT (4)

IDH1(14)

124

32

Secondary glioblastomas (21)

1p/19q (3)

1p/19q (5)

TERT (127)

None=50

IDH1(21)

Age group [30-49 y]

Age group [50-69 y]

Age group [70-90 y]

Gender (male)

TERT mutation

IDH1 mutation

EGFR amplification

TP53 mutation

PTEN mutaion

p16INK4a deletion

LOH 10q

LOH 1p

LOH 19q

P<0.05

*

*

Supplementary Fig. 2

*